How much does a box of imported Adagrasib cost?

Adagrasib is a targeted drug mainly used to treat non-small cell lung cancer (NSCLC) carrying KRAS G12C mutation. This specific gene mutation is relatively common in lung cancer and has long been considered difficult to target. The development of adagrasib has overcome this problem. Clinical trials have shown that in such patients, adagrasib can effectively inhibit the growth of cancer cells, providing patients with a new treatment option.

Adagrasib is not currently available in the country, so patients cannot purchase it domestically and can only purchase adagrasib through overseas channels. Abroad, there is only the original American drug adagrasib, and the price is very high, as high as about 190,000 yuan.

Adagrasiib is particularly important in situations where patients have developed resistance after other treatments. For patients with KRAS G12C mutations who have received other treatments and developed resistance, adagrasib provides a new treatment path. Its unique mechanism of action makes it specific for mutations produced in cell signaling pathways, thereby more effectively intervening in the proliferation of cancer cells and bringing new hope to drug-resistant patients.

The clinical application of adagrasib represents a major step towards personalized treatment. By selectively applying this drug based on a patient's genetic profile, doctors can more precisely tailor treatments to maximize efficacy and reduce unnecessary side effects. In the future, with a deeper understanding of the molecular mechanisms of diseases such as lung cancer, targeted drugs such as adagrasib may become models of personalized treatment, bringing more precise and effective treatment options to cancer patients.